Funding · Company
NanoCellect Biomedical, Inc.
San Diego, CABiotech & Pharma
NanoCellect Biomedical, Inc. of San Diego, CA has disclosed $49M across 2 Form D offerings filed with the SEC between Aug 27, 2021 and Jun 30, 2023.
$49M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$29M
Form D · Jun 30, 2023 ↗
Q2 2023
· target $39M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001658031Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →